Hacker Newsnew | past | comments | ask | show | jobs | submitlogin

I disagree. This article is typical embellishment from the university that produced the research. The reality is that they're likely pre-trial stage. Even if they make it through all stages of clinical trials (historically, chances of a drug candidate doing that are 2-5%), that usually takes the better part of a decade. So the answer is "no, we're very far from curing it".


They're at phase 2a trial stage, study start was at 2024-06-05, completion estimated 2025-12:

https://clinicaltrials.gov/study/NCT06393452?term=pp405&rank...




Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: